CERT Certara, Inc. - Common Stock

NAS · US · Healthcare · Health Information Services · certara.com

9.395USD+0.37%Mkt Cap: 1.43B $P/E: —Today

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access i…

Industry Peers

Health Information Services

Screen all

VEEV

Veeva Systems Inc. Class A Common Stock

$44.25BUSDP/E 44.9

TEM

Tempus AI, Inc. - Class A Common Stock

$13.83BUSD

BTSG

BrightSpring Health Services, Inc. - Common Stock

$11.92BUSDP/E 53.8

HNGE

Hinge Health, Inc. Class A Common Stock

$7.88BUSDP/E 11.9

HQY

HealthEquity, Inc. - Common Stock

$7.45BUSDP/E 32.5

DOCS

Doximity, Inc. Class A Common Stock

$4.98BUSDP/E 31.0

WAY

Waystar Holding Corp. - Common Stock

$4.76BUSDP/E 35.4

HTFL

Heartflow, Inc. - Common Stock

$4.29BUSD

PRVA

Privia Health Group, Inc. - Common Stock

$2.59BUSDP/E 92.3

SDGR

Schrodinger, Inc. - Common Stock

$2.27BUSD

OMCL

Omnicell, Inc. - Common Stock

$1.53BUSDP/E 40.0

OMDA

Omada Health, Inc. - Common Stock

$1.25BUSDP/E 30.4

GDRX

GoodRx Holdings, Inc. - Class A Common Stock

$1.12BUSDP/E 54.7

TDOC

Teladoc Health, Inc. Common Stock

$1.00BUSD

HSTM

HealthStream, Inc. - Common Stock

$942.97MUSDP/E 42.8

SOPH

SOPHiA GENETICS SA - Ordinary Shares

$686.98MUSD

PHR

Phreesia, Inc. Common Stock

$625.05MUSDP/E 55.9

WEAV

Weave Communications, Inc. Common Stock

$592.92MUSD

RAY-B

RaySearch Laboratories AB Class B

Key Statistics

Company

Market Cap1.43B USD

Enterprise Value1.54B USD

Revenue (TTM)421.75M USD

Gross Profit257.71M USD

Net Income (TTM)-1.59M USD

Revenue/Share2.67 USD

Last Price9.395 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.5K

CountryUS

SectorHealthcare

IndustryHealth Information Services

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)23.96

PEG—

EV/EBITDA16.39

EV/Revenue3.66

P/S3.39

P/B1.48

EPS (TTM)-0.14

EPS (Forward)0.39

52W Range

4.45052% of range13.88

52W High13.88 USD

52W Low4.450 USD

Profitability

Gross Margin61.53%

Oper. Margin-0.21%

EBITDA Margin22.35%

Profit Margin-0.38%

ROE-0.15%

ROA-0.10%

Growth

Revenue Growth1.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF96.33M USD

CapEx (TTM)26.56M USD

FCF Margin14.84%

FCF Yield4.38%

Net Debt117.08M USD

Net Debt/EBITDA1.24

Balance Sheet

Debt/Equity0.29

Current Ratio2.55

Quick Ratio2.44

Book Value/Sh6.34 USD

Cash/Share1.21 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.4 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)8.486 USD

Upside (mean)-9.7%

Target Range7.000 USD – 10.00 USD

7.000-9.7% to mean10.00

# Analysts11

Ownership

Shares Out.152.54M

Float111.95M

Insiders2.73%

Institutions112.88%

Short Interest

Short Ratio13.8d

Short % Float29.59%

Short % Out.18.89%

Shares Short28.81M

Short (prev mo.)25.23M

Technical

SMA 508.266 (+13.7%)

SMA 2007.184 (+30.8%)

Beta1.41

S&P 52W Chg14.58%

Avg Vol (30d)2.58M

Avg Vol (10d)2.78M

Technical Indicators

RSI (14)69.6

MACD0.3927

MACD Signal0.3122

MACD Hist.+0.0805

BB Upper9.765 USD

BB Middle8.489 USD

BB Lower7.214 USD

BB Width30.05%

ATR (14)0.3669 USD

Vol Ratio (20d)1.01x